Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fibroblast Consulting is a life sciences consulting firm based in Vancouver, Canada, led by Dr. Dmitri Petchkovski. The company specializes in providing preclinical research services and scientific advisory to biotechnology and pharmaceutical companies, particularly in the fields of oncology and respiratory medicine. A key highlight of the firm's work was its collaboration with Veritas Pharma and Cannevert Therapeutics to evaluate the efficacy of medical cannabis extracts against a range of human cancer cell lines, including lung, prostate, and breast cancer. Dr. Petchkovski, the principal, leverages his deep expertise in fibroblast biology and lung tissue remodeling to support drug discovery programs. Although the firm was primarily active in the late 2010s, it provided critical data for the development of therapeutic candidates targeting inflammatory and fibrotic pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fibroblast Consulting.